NASDAQ:ACB Aurora Cannabis (ACB) Stock Price, News & Analysis $3.46 -0.10 (-2.81%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$3.44 -0.02 (-0.66%) As of 05/22/2026 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Aurora Cannabis Stock (NASDAQ:ACB) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Aurora Cannabis alerts:Sign Up Key Stats Today's Range$3.46▼$3.6050-Day Range$3.08▼$3.8052-Week Range$3.07▼$6.66Volume414,727 shsAverage Volume824,727 shsMarket Capitalization$204.52 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company Overview Aurora Cannabis Inc. (NASDAQ: ACB) is a Canadian licensed producer of medical and consumer cannabis products headquartered in Edmonton, Alberta. Established in 2013, the company operates under Health Canada’s regulations to cultivate, process and distribute a range of cannabis-based offerings. Since its initial public listing in 2017, Aurora has grown into one of the country’s largest growers by cultivation capacity and production output. The company’s core business spans the cultivation of dried flower, the extraction of cannabis oils and the development of value-added products such as softgels, capsules and topical treatments. Aurora serves both the medical market—with products distributed through physicians and pharmacies—and the adult‐use market in jurisdictions where recreational cannabis is legal. Its portfolio includes proprietary genetics and branded offerings designed to deliver consistent cannabinoid and terpene profiles. Aurora operates several state-of-the-art production facilities, including high-tech greenhouses and indoor cultivation sites, most notably the Aurora Sky campus near Edmonton. The company holds EU Good Manufacturing Practice (GMP) certification, enabling exports to key European markets such as Germany, Italy and Denmark, and maintains partnerships in Latin America, Australia and parts of the Asia Pacific region. Through strategic investments and acquisition of international distribution platforms, Aurora seeks to extend its reach into emerging cannabis markets. Leadership at Aurora Cannabis has evolved since its founding, with Chairman and Chief Executive Officer Miguel Martin overseeing a shift toward operational efficiency and product innovation. The company’s early leadership team included co-founders Terry Booth and Steve Dobler, who guided initial expansion and public-market entry. Aurora has also pursued notable acquisitions—such as MedReleaf in 2018—to bolster production capacity and diversify its product mix. Looking ahead, Aurora aims to leverage its research capabilities and global infrastructure to capture growth opportunities in both medical and adult-use cannabis sectors.AI Generated. May Contain Errors. Read More Aurora Cannabis Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks19th Percentile Overall ScoreACB MarketRank™: Aurora Cannabis scored higher than 19% of companies evaluated by MarketBeat, and ranked 797th out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.2 / 5Analyst RatingHold Consensus RatingAurora Cannabis has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageAurora Cannabis has only been the subject of 1 research reports in the past 90 days.Read more about Aurora Cannabis' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Aurora Cannabis are expected to decrease in the coming year, from $0.16 to ($0.26) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Aurora Cannabis is -3.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aurora Cannabis is -3.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAurora Cannabis has a P/B Ratio of 0.44. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Aurora Cannabis' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted13.00% of the float of Aurora Cannabis has been sold short.Short Interest Ratio / Days to CoverAurora Cannabis has a short interest ratio ("days to cover") of 3.29, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Aurora Cannabis has recently increased by 14.81%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAurora Cannabis does not currently pay a dividend.Dividend GrowthAurora Cannabis does not have a long track record of dividend growth. News and Social Media2.9 / 5News Sentiment0.66 News SentimentAurora Cannabis has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Aurora Cannabis this week, compared to 3 articles on an average week.Search InterestOnly 10 people have searched for ACB on MarketBeat in the last 30 days. This is a decrease of -44% compared to the previous 30 days.MarketBeat Follows16 people have added Aurora Cannabis to their MarketBeat watchlist in the last 30 days. This is an increase of 1,500% compared to the previous 30 days. Company Ownership0.6 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Aurora Cannabis insiders have not sold or bought any company stock.Percentage Held by Insiders0.01% of the stock of Aurora Cannabis is held by insiders.Percentage Held by Institutions47.63% of the stock of Aurora Cannabis is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Aurora Cannabis' insider trading history. Receive ACB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aurora Cannabis and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ACB Stock News HeadlinesAurora Cannabis Sets August 7, 2026 Virtual AGM and Confirms June 15 Record DateMay 23 at 9:10 AM | theglobeandmail.comCannabis Pharmaceuticals Business Research Report 2026: An $111.1 Billion Market by 2032 from $4.7 Billion in 2025 Featuring AbbVie, Aphria, Aurora Cannabis, Bausch Health, and Canopy GrowthMay 18, 2026 | finance.yahoo.comTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result. | Porter & Company (Ad)Aurora Cannabis Secures Canadian Plant Breeders’ Rights for Key Medical CultivarsMay 16, 2026 | theglobeandmail.comAurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis ScienceMay 14, 2026 | prnewswire.comAurora Cannabis Inc. stock falls Monday, underperforms marketMay 4, 2026 | marketwatch.comWeekly Roundup on the Cannabis Sector & Psychedelic SectorMay 4, 2026 | finance.yahoo.comAurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International MarketsApril 28, 2026 | prnewswire.comSee More Headlines ACB Stock Analysis - Frequently Asked Questions How have ACB shares performed this year? Aurora Cannabis' stock was trading at $4.22 at the beginning of 2026. Since then, ACB stock has decreased by 18.0% and is now trading at $3.46. How were Aurora Cannabis' earnings last quarter? Aurora Cannabis Inc. (NASDAQ:ACB) issued its quarterly earnings results on Wednesday, February, 4th. The company reported $0.09 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.10 by $0.01. The company had revenue of $68.59 million for the quarter, compared to analysts' expectations of $92.39 million. Aurora Cannabis had a negative trailing twelve-month return on equity of 0.04% and a negative net margin of 23.46%. Read the conference call transcript. When did Aurora Cannabis' stock split? Aurora Cannabis's stock reverse split on Tuesday, February 20th 2024.The 1-10 reverse split was announced on Tuesday, February 20th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. Does Aurora Cannabis have any subsidiaries? Aurora Cannabis subsidiaries include these companies: Reliva LLC, Whistler Medical Marijuana Corporation, ICC Labs Inc., Anandia Labs Inc, MedReleaf Corp., CanniMed Therapeutics Inc., Larssen Ltd, and more. Who are Aurora Cannabis' major shareholders? Aurora Cannabis' top institutional shareholders include Renaissance Technologies LLC (1.28%), AdvisorShares Investments LLC (0.29%), Leonteq Securities AG (0.07%) and Silver Oak Securities Incorporated (0.06%). How do I buy shares of Aurora Cannabis? Shares of ACB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Aurora Cannabis own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aurora Cannabis investors own include Canopy Growth (CGC), Cronos Group (CRON), NVIDIA (NVDA), Meta Platforms (META), Humana (HUM), American Water Works (AWK). Company Calendar Last Earnings2/04/2026Today5/23/2026Next Earnings (Estimated)6/17/2026AGM 20268/07/2026Fiscal Year End3/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (3m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 ACB's financial health is in the Red zone, according to TradeSmith. ACB has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:ACB Previous SymbolNYSE:ACB CIK1683541 Webauroramj.com Phone(855) 279-4652FaxN/AEmployees1,130Year Founded2006Profitability EPS (Trailing Twelve Months)($1.08) Trailing P/E RatioN/A Forward P/E Ratio21.63 P/E GrowthN/ANet Income$1.63 million Net Margins-23.46% Pretax Margin-23.39% Return on Equity-0.04% Return on Assets-0.03% Debt Debt-to-Equity Ratio0.06 Current Ratio3.06 Quick Ratio1.48 Sales & Book Value Annual Sales$246.72 million Price / Sales0.83 Cash Flow$0.61 per share Price / Cash Flow5.66 Book Value$7.78 per share Price / Book0.44Miscellaneous Outstanding Shares59,110,000Free Float59,100,000Market Cap$204.52 million OptionableOptionable Beta0.51 Social Links 5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (NASDAQ:ACB) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredYour computer is about to become a museum pieceFuturist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredYou have until June 1Macroeconomic strategist Dr. Mark Skousen believes June 1 marks a critical turning point for one of the most o...The Oxford Club | SponsoredI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...Brownstone Research | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurora Cannabis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurora Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
